Abstract
Bacterial extracellular vesicles (EVs) contain numerous active substances that mediate bacterial interactions with their host and with other microbes. Best defined are the EVs from Gram-negative bacteria that have been shown to deliver virulence factors, modulate the immune responses, mediate antibiotic resistance, and also inhibit competitive microbes. Due to the complex cell wall structures of Gram-positive bacteria and mycobacteria, EVs from these bacteria were only recently reported. This protocol describes the isolation of EVs from mycobacteria.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
(WHO) WHO (2021) Global tuberculosis report 2021, p 25. ISBN: 978–92–4-003702-1
Mourenza ÁGJ, Mateos LM, Letek M (2020) Novel treatments against Mycobacterium tuberculosis based on drug repurposing. Antibiotics 9(9):550
Walzl G, Ronacher K, Djoba Siawaya JF, Dockrell HM (2008) Biomarkers for TB treatment response: challenges and future strategies. J Infect 57(2):103–109
Ginsberg AM, Spigelman M (2007) Challenges in tuberculosis drug research and development. Nat Med 13(3):290–294
Fernandes GFS, Thompson AM, Castagnolo D, Denny WA, Dos Santos JL (2022) Tuberculosis drug discovery: challenges and new horizons. J Med Chem 65(11):7489–7531
Kumar M, Singh SK, Singh PP, Singh VK, Rai AC, Srivastava AK et al (2021) Potential anti-Mycobacterium tuberculosis activity of plant secondary metabolites: insight with molecular docking interactions. Antioxidants (Basel) 10(12):1990
Maiolini M, Gause S, Taylor J, Steakin T, Shipp G, Lamichhane P et al (2020) The war against tuberculosis: a review of natural compounds and their derivatives. Molecules 25(13)
Quan D, Nagalingam G, Payne R, Triccas JA (2017) New tuberculosis drug leads from naturally occurring compounds. Int J Infect Dis 56:212–220
Tenland E, Krishnan N, Ronnholm A, Kalsum S, Puthia M, Morgelin M et al (2018) A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis. Tuberculosis (Edinb) 113:231–238
Tenland E, Pochert A, Krishnan N, Umashankar Rao K, Kalsum S, Braun K et al (2019) Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles. PLoS One 14(2):e0212858
Rao KU, Henderson DI, Krishnan N, Puthia M, Glegola-Madejska I, Brive L et al (2021) A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy. Sci Rep 11(1):4201
Prados-Rosales R, Baena A, Martinez LR, Luque-Garcia J, Kalscheuer R, Veeraraghavan U et al (2011) Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest 121(4):1471–1483
Caruana JC, Walper SA (2020) Bacterial membrane vesicles as mediators of microbe – microbe and microbe – host community interactions. Front Microbiol 11:432
Prados-Rosales R, Weinrick BC, Pique DG, Jacobs WR Jr, Casadevall A, Rodriguez GM (2014) Role for Mycobacterium tuberculosis membrane vesicles in iron acquisition. J Bacteriol 196(6):1250–1256
Chiplunkar SS, Silva CA, Bermudez LE, Danelishvili L (2019) Characterization of membrane vesicles released by Mycobacterium avium in response to environment mimicking the macrophage phagosome. Future Microbiol 14:293–313
Dauros Singorenko PCV, Whitcombe A, Simonov D, Hong J, Phillips A, Swift S, Blenkiron C (2017) Isolation of membrane vesicles from prokaryotes: a technical and biological comparison reveals heterogeneity. J Extracell Vesicles 6(1):1324731
Prados-Rosales R, Brown L, Casadevall A, Montalvo-Quiros S, Luque-Garcia JL (2014) Isolation and identification of membrane vesicle-associated proteins in Gram-positive bacteria and mycobacteria. MethodsX 1:124–129
Prados-Rosales R, Carreno LJ, Batista-Gonzalez A, Baena A, Venkataswamy MM, Xu J et al (2014) Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis. MBio 5(5):e01921–e01914
Yuan F, Li YM, Wang Z (2021) Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation. Drug Deliv 28(1):1501–1509
Bos J, Cisneros LH, Mazel D (2021) Real-time tracking of bacterial membrane vesicles reveals enhanced membrane traffic upon antibiotic exposure. Sci Adv 7(4):eabd1033
Klimentova J, Stulik J (2015) Methods of isolation and purification of outer membrane vesicles from gram-negative bacteria. Microbiol Res 170:1–9
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Rao, K.U., Godaly, G. (2023). Isolation and Purification of Mycobacterial Extracellular Vesicles (EVs). In: Nordenfelt, P., Collin, M. (eds) Bacterial Pathogenesis. Methods in Molecular Biology, vol 2674. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3243-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3243-7_3
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3242-0
Online ISBN: 978-1-0716-3243-7
eBook Packages: Springer Protocols